Abstract
Program implementers and qualitative researchers have described how increasing availability of HIV antiretroviral therapy (ART) is associated with improvements in psychosocial health and internalized stigma. To determine whether, and through what channels, ART reduces internalized stigma, we analyzed data from 262 HIV-infected, treatment-naïve persons in rural Uganda followed from ART initiation over a median of 3.4 years. We fitted Poisson regression models with cluster-correlated robust estimates of variance, specifying internalized stigma as the dependent variable, adjusting for time on treatment as well as socio-demographic, clinical, and psychosocial variables. Over time on treatment, internalized stigma declined steadily, with the largest decline observed during the first 2 years of treatment. This trend remained statistically significant after multivariable adjustment (χ2 = 28.3; P = 0.03), and appeared to be driven by ART-induced improvements in HIV symptom burden, physical and psychological wellbeing, and depression symptom severity.
Similar content being viewed by others
References
Weiser SD, Gupta R, Tsai AC, Frongillo EA, Grede N, Kumbakumba E, et al. Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda. J Acquir Immune Defic Syndr. 2012;61(2):179–86.
Palar K, Wagner G, Ghosh-Dastidar B, Mugyenyi P. Role of antiretroviral therapy in improving food security among patients initiating HIV treatment and care in Uganda. AIDS. 2012;26(18):2375–81.
Wagner GJ, Ghosh-Dastidar B, Garnett J, Kityo C, Mugyenyi P. Impact of HIV antiretroviral therapy on depression and mental health among clients with HIV in Uganda. Psychosom Med. 2012;74(9):883–90.
Rabkin JG, Ferrando SJ, Lin SH, Sewell M, McElhiney M. Psychological effects of HAART: a 2-year study. Psychosom Med. 2000;62(3):413–22.
Brent RJ. The effects of HIV medications on the quality of life of older adults in New York city. Health Econ. 2012;21(8):967–76.
Low-Beer S, Chan K, Yip B, Wood E, Montaner JS, O’Shaughnessy MV, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000;23(4):295–301.
Thirumurthy H, Zivin JG, Goldstein M. The economic impact of AIDS treatment: labor supply in western Kenya. J Hum Resour. 2008;43(3):511–52.
Wolfe WR, Weiser SD, Leiter K, Steward WT, Percy-de Korte F, Phaladze N, et al. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. Am J Public Health. 2008;98(10):1865–71.
Baranov V, Bennett D, Kohler H-P. The indirect impact of antiretroviral therapy. Population Studies Center Working Paper Series, PSC 12-08. Philadelphia: University of Pennsylvania, 2012.
Khandelwal S, Avode G, Baingana F, Conde B, Cruz M, Deva P, et al. Mental and neurological health research priorities setting in developing countries. Soc Psychiatry Psychiatr Epidemiol. 2010;45(4):487–95.
Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF, et al. Post-traumatic stress disorder (PTSD) after stigma related events in HIV infected individuals in Nigeria. Soc Psychiatry Psychiatr Epidemiol. 2009;44(9):761–6.
Jones EE, Farina A, Hastorf AH, Markus H, Miller DT, Scott RA. Social stigma: the psychology of marked relationships. New York: W.H. Freeman and Company; 1984.
Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape town, South Africa. Soc Sci Med. 2007;64(9):1823–31.
Tsai AC, Bangsberg DR, Frongillo EA, Hunt PW, Muzoora C, Martin JN, et al. Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Soc Sci Med. 2012;74(12):2012–9.
Norman A, Chopra M, Kadiyala S. Factors related to HIV disclosure in 2 South African communities. Am J Public Health. 2007;97(10):1775–81.
Boyer S, Clerc I, Bonono C-R, Marcellin F, Bile P-C, Ventelou B. Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: individual and healthcare supply-related factors. Soc Sci Med. 2011;72(8):1383–92.
Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001;358(9279):404–9.
Farmer P, Leandre F, Mukherjee J, Gupta R, Tarter L, Kim JY. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bull World Health Organ. 2001;79(12):1145–51.
Castro A, Farmer P. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health. 2005;95(1):53–9.
Gilbert L, Walker L. ‘My biggest fear was that people would reject me once they knew my status…’: stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa. Health Soc Care Community. 2010;18(2):139–46.
Zuch M, Lurie M. ‘A virus and nothing else’: the effect of ART on HIV-related stigma in rural South Africa. AIDS Behav. 2012;16(3):564–70.
Gilbert L, Walker L. “They (ARVs) are my life, without them I’m nothing”–experiences of patients attending a HIV/AIDS clinic in Johannesburg, South Africa. Health Place. 2009;15(4):1123–9.
Campbell C, Skovdal M, Madanhire C, Mugurungi O, Gregson S, Nyamukapa C. “We, the AIDS people…“: how antiretroviral therapy enables Zimbabweans living with HIV/AIDS to cope with stigma. Am J Public Health. 2011;101(6):1004–10.
Kaai S, Bullock S, Sarna A, Chersich M, Luchters S, Geibel S, et al. Perceived stigma among patients receiving antiretroviral treatment: a prospective randomised trial comparing an m-DOT strategy with standard-of-care in Kenya. SAHARA J. 2010;7(2):62–70.
Makoae LN, Portillo CJ, Uys LR, Dlamini PS, Greeff M, Chirwa M, et al. The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS Care. 2009;21(11):1357–62.
Munoz M, Finnegan K, Zeladita J, Caldas A, Sanchez E, Callacna M, et al. Community-based DOT-HAART accompaniment in an urban resource-poor setting. AIDS Behav. 2010;14(3):721–30.
Pearson CR, Micek MA, Pfeiffer J, Montoya P, Matediane E, Jonasse T, et al. One year after ART initiation: psychosocial factors associated with stigma among HIV-positive Mozambicans. AIDS Behav. 2009;13(6):1189–96.
Kinyanda E, Woodburn P, Tugumisirize J, Kagugube J, Ndyanabangi S, Patel V. Poverty, life events and the risk for depression in Uganda. Soc Psychiatry Psychiatr Epidemiol. 2011;46(1):35–44.
Ovuga E, Boardman J, Wasserman D. The prevalence of depression in two districts of Uganda. Soc Psychiatry Psychiatr Epidemiol. 2005;40(6):439–45.
Wilk CM, Bolton P. Local perceptions of the mental health effects of the Uganda acquired immunodeficiency syndrome epidemic. J Nerv Ment Dis. 2002;190(6):394–7.
Geng EH, Bwana MB, Kabakyenga J, Muyindike W, Emenyonu NI, Musinguzi N, et al. Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda. PLoS One. 2010;5(11):e14098.
Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, et al. Rethinking the “pre” in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012;7(6):e39894.
Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2009;21(1):87–93.
Tsai AC, Weiser SD, Steward WT, Mukiibi NF, Kawuma A, Kembabazi A, et al. Evidence for the reliability and validity of the Internalized AIDS-Related Stigma Scale in rural Uganda. AIDS Behav. 2013;17(1):427–33.
Tsai AC, Bangsberg DR, Kegeles SM, Katz IT, Haberer JE, Muzoora C, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013 (in press).
Kling JR, Liebman JB, Katz LF. Experimental analysis of neighborhood effects. Econometrica. 2007;75(1):83–119.
Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT, Hardy WD, et al. A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Med Care. 1991;29(8):786–98.
Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.
Bolton P. Cross-cultural validity and reliability testing of a standard psychiatric assessment instrument without a gold standard. J Nerv Ment Dis. 2001;189(4):238–42.
Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188(10):662–70.
Filmer D, Pritchett LH. Estimating wealth effects without expenditure data—or tears: an application to educational enrollments in states of India. Demography. 2001;38(1):115–32.
Young SD, Hlavka Z, Modiba P, Gray G, Van Rooyen H, Richter L, et al. HIV-related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J Acquir Immune Defic Syndr. 2010;55(5):620–4.
Weiser SD, Heisler M, Leiter K, Percy-de Korte F, Tlou S, DeMonner S, et al. Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med. 2006;3(7):e261.
Musheke M, Ntalasha H, Gari S, McKenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Pub Health. 2013;13:220.
Musheke M, Bond V, Merten S. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study. AIDS Patient Care STDs. 2013;27(4):231–41.
Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR. HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav. 2011;15(6):1111–20.
Pollini RA, Blanco E, Crump C, Zuniga ML. A community-based study of barriers to HIV care initiation. AIDS Patient Care STDS. 2011;25(10):601–9.
Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52(2):280–9.
Muhamadi L, Nsabagasani X, Tumwesigye MN, Wabwire-Mangen F, Ekstrom AM, Peterson S, et al. Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD < 350 cells/microL) in eastern Uganda. Health Policy. 2010;97(2–3):187–94.
Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24(10):1101–8.
Judd CM, Kenny DA. Process analysis: estimating mediation in treatment evaluations. Eval Rev. 1981;5(5):602–19.
James LR, Brett JM. Mediators, moderators, and tests for mediation. J Appl Psychol. 1984;69(2):307–21.
Valeri L, VanderWeele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013. doi:10.1037/a0031034.
Sengupta S, Banks B, Jonas D, Miles MS, Smith GC. HIV interventions to reduce HIV/AIDS stigma: a systematic review. AIDS Behav. 2011;15(6):1075–87.
Yamano T, Jayne TS. Measuring the impact of working-age adult mortality on small-scale farm households in Kenya. World Dev. 2004;32(1):91–119.
Wagner G, Ryan G, Huynh A, Kityo C, Mugyenyi P. A qualitative analysis of the economic impact of HIV and antiretroviral therapy on individuals and households in Uganda. AIDS Patient Care STDS. 2009;23(9):793–8.
Samuels FA, Rutenberg N. “Health regains but livelihoods lag”: findings from a study with people on ART in Zambia and Kenya. AIDS Care. 2011;23(6):748–54.
Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;11(3):353–63.
Goudge J, Ngoma B, Manderson L, Schneider H. Stigma, identity and resistance among people living with HIV in South Africa. SAHARA J. 2009;6(3):94–104.
Reidpath DD, Chan KY, Gifford SM, Allotey P. ‘He hath the French pox’: stigma, social value and social exclusion. Sociol Health Illn. 2005;27(4):468–89.
Acknowledgments
We thank the Uganda AIDS Rural Treatment Outcomes (UARTO) study participants who made this study possible by sharing their experiences; Nozmo F.B. Mukiibi for his contributions to study design and implementation; and Annet Kembabazi and Annet Kawuma for providing study coordination and administrative support. While these individuals are acknowledged for their assistance, no endorsement of manuscript contents or conclusions should be inferred. A preliminary version of this analysis was presented in part at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, Georgia, USA, March 4, 2013. This study was funded by U.S. National Institutes of Health R01 MH-054907, K23 MH-079713, K23 MH-079713-03S1, and P30 AI-027763. Additionally, the authors acknowledge the following sources of salary support: K23 MH-096620 (Tsai), K24 MH-087227 (Bangsberg), K23 MH-087228 (Haberer), and the Burke Family Foundation (Weiser).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsai, A.C., Bangsberg, D.R., Bwana, M. et al. How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence from a Cohort Study in Rural Uganda. AIDS Behav 17, 2725–2731 (2013). https://doi.org/10.1007/s10461-013-0503-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-013-0503-3